Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss


      The prevalence of lower extremity reamputation in diabetic patients has been well-documented. We sought to determine the risk factors for major lower extremity amputation (LEA) after minor foot amputation in diabetic patients. We studied 163 diabetic patients who had undergone an initial minor foot amputation and then had undergone at least 1 subsequent major or minor LEA. The patients were separated into a minor LEA group (initial minor LEA followed by at least 1 subsequent minor LEA) and a major LEA group (initial minor LEA followed by at least 1 subsequent major LEA). We then studied the possible risk factors for both groups. The possible risk factors analyzed were age, glycemic control, kidney function, previous kidney or kidney–pancreas transplantation, smoking history, and presence and severity of peripheral arterial disease (PAD). No statistical significance was found between the 2 groups for hemoglobin A1c, smoking status, chronic kidney disease, end-stage renal disease requiring dialysis, kidney or kidney-pancreas transplantation, or vascular intervention (peripheral arterial bypass). In the minor group, 22.23% had severe PAD. In the major group, 71.15% had severe PAD. This was statistically significant (p < .001). The average interval to major amputation in those without PAD, mild to moderate PAD, and severe PAD was 1,180.9, 591.0, and 559.6 days, respectively. This demonstrates the importance of assessing the peripheral vascular status in all diabetic patients with minor LEA. Early referral to a vascular surgeon might delay (or prevent) major LEA.

      Level of Clinical Evidence


      To read this article in full you will need to make a payment


        • Izumi Y.
        • Satterfield K.
        • Lee S.
        • Harkless L.B.
        Risk of reamputation in diabetic patients stratified by limb and level of amputation: a 10-year observation.
        Diabetes Care. 2006; 29: 566-570
        • Aulivola B.
        • Hile C.N.
        • Hamdan A.D.
        • Sheahan M.G.
        • Veraldi J.R.
        • Skillman J.J.
        • Campbell D.R.
        • Scovell S.D.
        • LoGerfo F.W.
        • Pomposelli Jr., F.B.
        Major lower extremity amputation: outcome of a modern series.
        Arch Surg. 2004; 139: 395-399
        • Snyder D.C.
        • Salameh J.R.
        • Clericuzio C.P.
        Retrospective review of forefoot amputations at a Veterans Affairs hospital and evaluation of post-amputation follow-up.
        Am J Surg. 2006; 192: e51-e54
        • Waters R.L.
        • Perry J.
        • Antonelli D.
        • Hislop H.
        Energy cost of walking of amputees: the influence of level of amputation.
        J Bone Joint Surg Am. 1976; 58: 42-46
        • Eckman M.H.
        • Greenfield S.
        • Mackey W.C.
        • Wong J.B.
        • Kaplan S.
        • Sullivan L.
        • Dukes K.
        • Pauker S.G.
        Foot infections in diabetic patients: decision and cost-effectiveness analyses.
        JAMA. 1995; 273: 712-720
      1. Veterans Health Administration. Veterans Health Administration Preservation-Amputation Care and Treatment program directive (2012), 2012–020, August. Available at: Accessed December 24, 2012.

        • Selby J.V.
        • Zhang D.
        Risk factors for lower extremity amputation in persons with diabetes.
        Diabetes Care. 1995; 18: 509-516
        • Reiber G.E.
        • Pecoraro R.E.
        • Koepsell T.D.
        Risk factors for amputation in patients with diabetes mellitus: a case-control study.
        Ann Intern Med. 1992; 117: 97-105
        • Reiber G.E.
        • Vileikyte L.
        • Boyko E.J.
        • del Aguila M.
        • Smith D.G.
        • Lavery L.A.
        • Boulton A.J.
        Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
        Diabetes Care. 1999; 22: 157-162
        • Young B.A.
        • Maynard C.
        • Reiber G.
        • Boyko E.J.
        Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans.
        Diabetes Care. 2003; 26: 495-501
        • Lehto S.
        • Ronnemaa T.
        • Pyorala K.
        • Laakso M.
        Risk factors predicting lower extremity amputations in patients with NIDDM.
        Diabetes Care. 1996; 19: 607-612
        • Malay D.S.
        • Margolis D.J.
        • Hoffstad O.J.
        • Bellamy S.
        The incidence and risks of failure to heal after lower extremity amputation for the treatment of diabetic neuropathic foot ulcer.
        J Foot Ankle Surg. 2006; 45: 366-374
        • Boyko E.J.
        • Ahroni J.H.
        • Stensel V.
        • Forsberg R.C.
        • Davignon D.R.
        • Smith D.G.
        A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot study.
        Diabetes Care. 1999; 22: 1036-1042
        • Reichard P.
        • Nilsson B.Y.
        • Rosenqvist U.
        The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.
        N Engl J Med. 1993; 329: 304-309
        • Duckworth W.
        • Abraira C.
        • Moritz T.
        • Reda D.
        • Emanuele N.
        • Reaven P.D.
        • Zieve F.J.
        • Marks J.
        • Davis S.N.
        • Hayward R.
        • Warren S.R.
        • Goldman S.
        • McCarren M.
        • Vitek M.E.
        • Henderson W.G.
        • Huang G.D.
        VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes.
        N Engl J Med. 2009; 360: 129-139
      2. O'Connor DJ, Gargiulo NJ III, Jang J. Hemoglobin A1c as a measure of disease severity and outcome in limb threatening ischemia. J Surg Res Epub 2011 Jul 23.

        • Nather A.
        • Bee C.S.
        • Huak C.Y.
        • Chew J.L.
        • Lin C.B.
        • Neo S.
        • Sim E.Y.
        Epidemiology of diabetic foot problems and predictive factors for limb loss.
        J Diabetes Complications. 2008; 22: 77-82
        • Selvin E.
        • Marinopoulos S.
        • Berkenblit G.
        • Rami T.
        • Brancati F.L.
        • Powe N.R.
        • Golden S.H.
        Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
        Ann Intern Med. 2004; 141: 421-431
        • Adler A.I.
        • Boyko E.J.
        • Ahroni J.H.
        • Smith D.G.
        Lower-extremity amputation in diabetes: the independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.
        Diabetes Care. 1999; 22: 1029-1035
        • Younger A.S.
        • Awwad M.A.
        • Kalla T.P.
        • de Vries G.
        Risk factors for failure of transmetatarsal amputation in diabetic patients: a cohort study.
        Foot Ankle Int. 2009; 30: 1177-1182
        • Morbach S.
        • Quante C.
        • Ochs H.R.
        • Gaschler F.
        • Pallast J.M.
        • Knevels U.
        Increased risk of lower-extremity amputation among Caucasian diabetic patients on dialysis.
        Diabetes Care. 2001; 24: 1689-1690
        • McGrath N.M.
        • Curran B.A.
        Recent commencement of dialysis is a risk factor for lower-extremity amputation in a high-risk diabetic population.
        Diabetes Care. 2000; 23: 432-433
        • Ndip A.
        • Rutter M.K.
        • Vileikyte L.
        • Vardhan A.
        • Asari A.
        • Jameel M.
        • Tahir H.A.
        • Lavery L.A.
        • Boulton A.J.
        Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease.
        Diabetes Care. 2010; 33: 1811-1816
        • Woeste G.
        • Wullstein C.
        • Pridohl O.
        • Lübke P.
        • Schwarz R.
        • Kohlhaw K.
        • Bechstein W.O.
        Incidence of minor and major amputations after pancreas/kidney transplantation.
        Transpl Int. 2003; 16: 128-132
        • Knight R.J.
        • Zela S.
        • Schoenberg L.
        • Podder H.
        • Kerman R.H.
        • Katz S.
        • Van Buren C.T.
        • Kahan B.D.
        The effect of pancreas transplantation on peripheral vascular disease complications.
        Transplant Proc. 2004; 36: 1069-1071
        • Faglia E.
        • Clerici G.
        • Clerissi J.
        • Gabrielli L.
        • Losa S.
        • Mantero M.
        • Caminiti M.
        • Curci V.
        • Lupattelli T.
        • Morabito A.
        Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients.
        Eur J Vasc Endovasc Surg. 2006; 32: 484-490
        • Dick F.
        • Diehm N.
        • Galimanis A.
        • Husmann M.
        • Schmidli J.
        • Baumgartner I.
        Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome.
        J Vasc Surg. 2007; 45: 751-761
        • Hirsch A.T.
        • Haskal Z.J.
        • Hertzer N.R.
        • Bakal C.W.
        • Creager M.A.
        • Halperin J.L.
        • Hiratzka L.F.
        • Murphy W.R.C.
        • Olin J.W.
        • Puschett J.B.
        • Rosenfield K.A.
        • Sacks D.
        • Stanley J.C.
        • Taylor Jr., L.M.
        • White C.J.
        • White J.
        • White R.A.
        • Antman E.M.
        • Smith Jr., S.C.
        • Adams C.D.
        • Anderson J.L.
        • Faxon D.P.
        • Fuster V.
        • Gibbons R.J.
        • Halperin J.L.
        • Hiratzka L.F.
        • Hunt S.A.
        • Jacobs A.K.
        • Nishimura R.
        • Ornato J.P.
        • Page R.L.
        • Riegel B.
        ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary—a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
        J Am Coll Cardiol. 2006; 47: 1239-1312